Dr. Luigi Aurisicchio, CEO/CSO at Takis and Evvivax flew to Lille to represent both the companies at BioFIT 2018. This is the place where academia-industry collaborations get started, an exceptional platform for tech transfer and partnership building.

Luigi Aurisicchio took part in a round-table discussing the translational potential of veterinary medicine to complement current human Immune-Oncology approaches in the next future.
“I was honoured to contribute to the discussion with Takis/Evvivax experience and biotech perspectives. The possibility to work both in the human and animal health space provides a truly unique position and allows to appreciate two different worlds which converge into the One health approach”, declared Luigi Aurisicchio.
We hope that common grounds in human and animal health could lead to more frequent and translationally relevant collaborations all over the world.